Newpath Partners | Activity | F4

Team Portfolio Raise Champions Essays

F4/Newpath Partners/Activity

Newpath Partners Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Investment

Co-led CREATE Medicines $122M Series B financing to advance in vivo CAR therapies.

CREATE Medicines

CREATE Medicines Newpath Partners

prnewswire.comMAY 14, 2026

MAY 14, 2026

Exit

Newpath Partners portfolio company Kisbee Therapeutics exited on December 16, 2025, acquired by Magnet Biomedicine (another Newpath portfolio company).

Kisbee Therapeutics

Kisbee TherapeuticsNewpath Partners

pitchbook.comDEC 16, 2025

DEC 16, 2025

Exit

Newpath Partners portfolio company YourBio Health exited on December 3, 2025.

YourBio Health

YourBio Health Newpath Partners

cbinsights.comDEC 3, 2025

DEC 3, 2025

Investment

Participated in Leal Therapeutics' $30M Series A financing for neuro-metabolic CNS therapeutics.

Leal Therapeutics

Leal Therapeutics Newpath Partners

lealtx.comAUG 27, 2025

AUG 27, 2025